Skip Navigation

JNCI Journal of the National Cancer Institute 1999 91(20):1718; doi:10.1093/jnci/91.20.1718
© 1999 by Oxford University Press
This Article
Right arrow Extract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 91, No. 20, 1718, October 20, 1999
© 1999 Oxford University Press

NEWS

NCI Funds Cancer Trials Support Unit

The National Cancer Institute has awarded the contract to build its new Cancer Trials Support Unit to Westat Corporation of Rockville, Md. The CTSU will provide unprecedented access to NCI-sponsored treatment trials by patients and new physician participants, said Jeff Abrams, M.D., who is coordinating this and other components of the institute's revamped clinical trials system.

The CTSU will allow web-based, online patient registration, eligibility assessment, and reporting of data on phase III trials. It will also facilitate education and training for medical staff along with referral and clinical trials information for patients. Westat vice president Steve Durako said the company aims to have a CTSU website ready for protocol and training materials in 3 to 6 months and that the first patients could be enrolled online in 6 to 9 months.

For investigators, the new CTSU means enhanced access to clinical trials and fewer redundant activities among the NCI-sponsored Cooperative Clinical Trials Groups, said Robert Comis, M.D., president of the Coalition of National Cancer Cooperative Groups, Inc., Philadelphia. Through a subcontract, the Coalition will help develop the CTSU in areas such as credentialing of investigators, auditing, education, and regulatory matters. Support for systems development will be provided by Oracle Corporation, Redwood City, Calif.

Michaele Christian, M.D., associate director of NCI's Cancer Therapy Evaluation Program, called the CTSU a cornerstone in the new clinical trials system, and added that it will dramatically change the way NCI's large treatment trials are organized (News, Feb. 17, 1999, p. 312). More information is available at http://ctep.info.nih.gov (click on clinical trials support initiatives).


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?